Human genetic modification. CRISPR explained, somatic versus germline editing, the diseases now treatable and the ones close. The 2018 embryo editing case and its aftermath. Embryo selection, polygenic scoring, and the market emerging around both.
Disability advocates, bioethicists, and clinicians who disagree with each other, given room to do so.